Inhibitory effects of epi-sesamin on HMGB1-induced vascular barrier disruptive responses in vitro and in vivo

Toxicology and Applied Pharmacology

Volumn 267, Issue 3, 2013, Pages 201-208

  Lee, Wonhwa ^a,b   Ku, Sae Kwang ^c   Kim, Jeong Ah ^a   Lee, Taeho ^a   Bae, Jong Sup ^a  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c Daegu Haany University   (South Korea)

Author keywords

Endothelium; Epi sesamin; HMGB1; Sepsis; Sesamin

Indexed keywords

EPI SESAMIN; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; SESAMIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE MIGRATION; MALE; MOUSE; NONHUMAN; PROTEIN SECRETION; VASCULITIS;

ANIMALS; CAPILLARY PERMEABILITY; CELL ADHESION; CELL SURVIVAL; DIOXOLES; HMGB1 PROTEIN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIGNANS; MALE; MICE; MICE, INBRED C57BL; SESAME OIL; VASCULITIS;

EID: 84873436135     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.01.008     Document Type: Article

References (57)

1. Akeson A.L., Woods C.W. A fluorometric assay for the quantitation of cell adherence to endothelial cells. J. Immunol. Methods 1993, 163:181-185.
2. Alipoor B., Haghighian M.K., Sadat B.E., Asghari M. Effect of sesame seed on lipid profile and redox status in hyperlipidemic patients. Int. J. Food Sci. Nutr. 2012, 63:674-678.
3. Andersson U., Tracey K.J. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 2011, 29:139-162.
4. Andersson U., Wang H., Palmblad K., Aveberger A.C., Bloom O., Erlandsson-Harris H., Janson A., Kokkola R., Zhang M., Yang H., Tracey K.J. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 2000, 192:565-570.
5. Ashakumary L., Rouyer I., Takahashi Y., Ide T., Fukuda N., Aoyama T., Hashimoto T., Mizugaki M., Sugano M. Sesamin, a sesame lignan, is a potent inducer of hepatic fatty acid oxidation in the rat. Metabolism 1999, 48:1303-1313.
6. Bae J.S. Role of high mobility group box 1 in inflammatory disease: focus on sepsis. Arch. Pharm. Res. 2012, 35:1511-1523.
7. Bae J.W., Bae J.S. Barrier protective effects of lycopene in human endothelial cells. Inflamm. Res. 2011, 60:751-758.
8. Bae J.S., Rezaie A.R. Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb. Haemost. 2008, 100:101-109.
9. Bae J.S., Rezaie A.R. Activated protein C inhibits high mobility group box 1 signaling in endothelial cells. Blood 2011, 118:3952-3959.
10. Bae J.S., Lee W., Rezaie A.R. Polyphosphate elicits proinflammatory responses that are counteracted by activated protein C in both cellular and animal models. J. Thromb. Haemost. 2012, 10:1145-1151.
11. Berman R.S., Frew J.D., Martin W. Endotoxin-induced arterial endothelial barrier dysfunction assessed by an in vitro model. Br. J. Pharmacol. 1993, 110:1282-1284.
12. Buras J.A., Holzmann B., Sitkovsky M. Animal models of sepsis: setting the stage. Nat. Rev. Drug. Discov. 2005, 4:854-865.
13. Che W., Lerner-Marmarosh N., Huang Q., Osawa M., Ohta S., Yoshizumi M., Glassman M., Lee J.D., Yan C., Berk B.C., Abe J. Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression. Circ. Res. 2002, 90:1222-1230.
14. Chen G., Li J., Ochani M., Rendon-Mitchell B., Qiang X., Susarla S., Ulloa L., Yang H., Fan S., Goyert S.M., Wang P., Tracey K.J., Sama A.E., Wang H. Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms. J. Leukoc. Biol. 2004, 76:994-1001.
15. El Gazzar M. HMGB1 modulates inflammatory responses in LPS-activated macrophages. Inflamm. Res. 2007, 56:162-167.
16. Fiuza C., Bustin M., Talwar S., Tropea M., Gerstenberger E., Shelhamer J.H., Suffredini A.F. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003, 101:2652-2660.
17. Fukuda Y., Isobe M., Nagata M., Owaea T., Namiki M. Acidic transformation of sesamolin, the sesame oil constituent, into an antioxidant bisepoxylignan, sesaminol. Heterocycles 1986, 24:923-926.
18. Gibot S., Massin F., Cravoisy A., Barraud D., Nace L., Levy B., Bollaert P.E. High-mobility group box 1 protein plasma concentrations during septic shock. Intensive Care Med. 2007, 33:1347-1353.
19. Goldblum S.E., Ding X., Brann T.W., Campbell-Washington J. Bacterial lipopolysaccharide induces actin reorganization, intercellular gap formation, and endothelial barrier dysfunction in pulmonary vascular endothelial cells: concurrent F-actin depolymerization and new actin synthesis. J. Cell. Physiol. 1993, 157:13-23.
20. Han A.R., Kim H.J., Shin M., Hong M., Kim Y.S., Bae H. Constituents of Asarum sieboldii with inhibitory activity on lipopolysaccharide (LPS)-induced NO production in BV-2 microglial cells. Chem. Biodivers. 2008, 5:346-351.
21. Hashimoto K., Yanagisawa T., Okui Y., Ikeya Y., Maruno M., Fujita T. Studies on anti-allergic components in the roots of Asiasarum sieboldii. Planta Med. 1994, 60:124-127.
22. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., Nagashima M., Lundh E.R., Vijay S., Nitecki D., Morser J., Stern D., Schmidt A.M. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 1995, 270:25752-25761.
23. Iwashina T., Kitajima J. Chalcone and flavonol glycosides from Asarum canadense (Aristolochiaceae). Phytochemistry 2000, 55:971-974.
24. Kamal-Eldin A., Moazzami A., Washi S. Sesame seed lignans: potent physiological modulators and possible ingredients in functional foods & nutraceuticals. Recent Pat. Food Nutr. Agric. 2011, 3:17-29.
25. Kelly L. Phylogenetic relationships in Asarum (Aristolochiaceae) based on morphology and ITS sequences. Am. J. Bot. 1998, 85:1454-1467.
26. Kim T.H., Bae J.S. Ecklonia cava extracts inhibit lipopolysaccharide induced inflammatory responses in human endothelial cells. Food Chem. Toxicol. 2010, 48:1682-1687.
27. Kim S.J., Gao Zhang C., Taek Lim J. Mechanism of anti-nociceptive effects of Asarum sieboldii Miq. radix: potential role of bradykinin, histamine and opioid receptor-mediated pathways. J. Ethnopharmacol. 2003, 88:5-9.
28. Kim T.H., Ku S.K., Bae J.S. Inhibitory effects of kaempferol-3-O-sophoroside on HMGB1-mediated proinflammatory responses. Food Chem. Toxicol. 2011, 50:1118-1123.
29. Lee J.Y., Moon S.S., Hwang B.K. Isolation and antifungal activity of kakuol, a propiophenone derivative from Asarum sieboldii rhizome. Pest Manag. Sci. 2005, 61:821-825.
30. Lee J.D., Huh J.E., Jeon G., Yang H.R., Woo H.S., Choi D.Y., Park D.S. Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models. Int. Immunopharmacol. 2009, 9:268-276.
31. Lee W., Kim T.H., Ku S.K., Min K.J., Lee H.S., Kwon T.K., Bae J.S. Barrier protective effects of withaferin A in HMGB1-induced inflammatory responses in both cellular and animal models. Toxicol. Appl. Pharmacol. 2012, 262:91-98.
32. Lee W., Ku S.K., Bae J.W., Bae J.S. Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory responses in both cellular and animal models. Food Chem. Toxicol. 2012, 50:1826-1833.
33. Lin W.N., Luo S.F., Wu C.B., Lin C.C., Yang C.M. Lipopolysaccharide induces VCAM-1 expression and neutrophil adhesion to human tracheal smooth muscle cells: involvement of Src/EGFR/PI3-K/Akt pathway. Toxicol. Appl. Pharmacol. 2008, 228:256-268.
34. Lockyer J.M., Colladay J.S., Alperin-Lea W.L., Hammond T., Buda A.J. Inhibition of nuclear factor-kappaB-mediated adhesion molecule expression in human endothelial cells. Circ. Res. 1998, 82:314-320.
35. Lotze M.T., Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 2005, 5:331-342.
36. Marui N., Offermann M.K., Swerlick R., Kunsch C., Rosen C.A., Ahmad M., Alexander R.W., Medford R.M. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Investig. 1993, 92:1866-1874.
37. Miyazawa M., Kohno G., Okuno Y., Oda Y. Suppression of MeIQ-induced SOS response by allylbenzenes from Asiasarum heterotropoides in the Salmonella typhimurium OY1001/1A2 umu test. Nat. Prod. Res. 2006, 20:671-675.
38. Mullins G.E., Sunden-Cullberg J., Johansson A.S., Rouhiainen A., Erlandsson-Harris H., Yang H., Tracey K.J., Rauvala H., Palmblad J., Andersson J., Treutiger C.J. Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1. Scand. J. Immunol. 2004, 60:566-573.
39. Palumbo R., Galvez B.G., Pusterla T., De Marchis F., Cossu G., Marcu K.B., Bianchi M.E. Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation. J. Cell Biol. 2007, 179:33-40.
40. Park J.S., Arcaroli J., Yum H.K., Yang H., Wang H., Yang K.Y., Choe K.H., Strassheim D., Pitts T.M., Tracey K.J., Abraham E. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Physiol. Cell Physiol. 2003, 284:C870-C879.
41. Park J.S., Svetkauskaite D., He Q., Kim J.Y., Strassheim D., Ishizaka A., Abraham E. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 2004, 279:7370-7377.
42. Park J.S., Gamboni-Robertson F., He Q., Svetkauskaite D., Kim J.Y., Strassheim D., Sohn J.W., Yamada S., Maruyama I., Banerjee A., Ishizaka A., Abraham E. High mobility group box 1 protein interacts with multiple toll-like receptors. Am. J. Physiol. Cell Physiol. 2006, 290:C917-C924.
43. Qin Y.H., Dai S.M., Tang G.S., Zhang J., Ren D., Wang Z.W., Shen Q. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products. J. Immunol. 2009, 183:6244-6250.
44. Rose B.A., Force T., Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol. Rev. 2010, 90:1507-1546.
45. Ruiz-Torres M.P., Perez-Rivero G., Rodriguez-Puyol M., Rodriguez-Puyol D., Diez-Marques M.L. The leukocyte-endothelial cell interactions are modulated by extracellular matrix proteins. Cell. Physiol. Biochem. 2006, 17:221-232.
46. Sama A.E., D'Amore J., Ward M.F., Chen G., Wang H. Bench to bedside: HMGB1-a novel proinflammatory cytokine and potential therapeutic target for septic patients in the emergency department. Acad. Emerg. Med. 2004, 11:867-873.
47. Sun C., Liang C., Ren Y., Zhen Y., He Z., Wang H., Tan H., Pan X., Wu Z. Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways. Basic Res. Cardiol. 2009, 104:42-49.
48. Sunden-Cullberg J., Norrby-Teglund A., Rouhiainen A., Rauvala H., Herman G., Tracey K.J., Lee M.L., Andersson J., Tokics L., Treutiger C.J. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit. Care Med. 2005, 33:564-573.
49. Treutiger C.J., Mullins G.E., Johansson A.S., Rouhiainen A., Rauvala H.M., Erlandsson-Harris H., Andersson U., Yang H., Tracey K.J., Andersson J., Palmblad J.E. High mobility group 1 B-box mediates activation of human endothelium. J. Intern. Med. 2003, 254:375-385.
50. Venkataraman R., Gopalakrishnan S. A lignan from the root of Ecbolium linneanum Kurz. Phytochemistry 2002, 61:963-966.
51. Wang H., Liao H., Ochani M., Justiniani M., Lin X., Yang L., Al-Abed Y., Metz C., Miller E.J., Tracey K.J., Ulloa L. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 2004, 10:1216-1221.
52. Wei F., Cheng X.L., Ma L.Y., Jin W.T., Schaneberg B.T., Khan I.A., Lin R.C. Analysis of aristolochic acids and analogues in medicinal plants and their commercial products by HPLC-PAD-ESI/MS. Phytochem. Anal. 2005, 16:222-230.
53. Wolfson R.K., Chiang E.T., Garcia J.G. HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption. Microvasc. Res. 2011, 81:189-197.
54. Yang H., Tracey K.J. Targeting HMGB1 in inflammation. Biochim. Biophys. Acta 2010, 1799:149-156.
55. Yang H., Wang H., Czura C.J., Tracey K.J. The cytokine activity of HMGB1. J. Leukoc. Biol. 2005, 78:1-8.
56. Yu H.H., Seo S.J., Hur J.M., Lee H.S., Lee Y.E., You Y.O. Asarum sieboldii extracts attenuate growth, acid production, adhesion, and water-insoluble glucan synthesis of Streptococcus mutans. J. Med. Food 2006, 9:505-509.
57. Zhang F., Chu C.H., Xu Q., Fu S.P., Hu J.H., Xiao H.B., Liang X.M. A new amide from Asarum forbesii Maxim. J. Asian Nat. Prod. Res. 2005, 7:1-5.